PAVM SEC Filings: 8-K, 10-Q, S-3 & 424B – PAVmed

Financials

TYPE

HEADLINE

FILED AT

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2026

10-K

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]

Mar 27, 2026

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Nov 12, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

Aug 13, 2025

10-Q

Form 10-Q - Quarterly report [Sections 13 or 15(d)]

May 14, 2025

News

TYPE

HEADLINE

FILED AT

8-K

Subsidiary Raises $15 Million Through Sale of Series C Convertible Preferred Stock to Accredited Investors

Oct 22, 2026

8-K

PAVmed Inc. Enters into $9.4 Million "At the Market" Sales Agreement with A.G.P./Alliance Global Partners

Sep 9, 2026

8-K

PAVmed Provides Business Update and Reports Second Quarter 2026 Financial Results

Aug 14, 2026

8-K

PAVmed Inc. Announces Results of 2026 Annual Meeting of Stockholders

Jun 24, 2026

8-K

PAVmed Reports First Quarter 2026 Financial Results and Provides Business Update

May 15, 2026

8-K

PAVmed Reports 2025 Financial Results and Provides Business Update

Mar 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

September 2026 ATM

Sep 9, 2026

424B3

SHARE RESALE REGISTRATION | Shares: 9,230,786

Apr 29, 2026

424B3

UPDATED | SHARE RESALE REGISTRATION | Shares amount: 3,331,084 | Share price: $0.71 | Warrants amount: 756,734

Apr 21, 2025

424B5

April 2025 ATM

Apr 17, 2025

424B5

ATM | Offering amount: $18,000,000 | Amount sold to date: $1,112,713 | Float: 97,526,253

May 30, 2023

424B5

SHELF OFFERING | Share price: $1,000.00 | Conversion price: $5.00 | Offering amount: $50,000,000.00

Apr 4, 2022

Registrations

TYPE

HEADLINE

FILED AT

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 29, 2026

S-3

SHARE RESALE REGISTRATION

Apr 20, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 1, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Apr 1, 2026

Form D - Notice of Exempt Offering of Securities - Item 06b

Feb 17, 2026

S-8

Form S-8 - Securities to be offered to employees in employee benefit plans

Jul 28, 2025

Proxies

TYPE

HEADLINE

FILED AT

DEF 14A

Form DEF 14A - Other definitive proxy statements

May 1, 2026

DEFA14A

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material

Apr 30, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Feb 24, 2026

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Feb 13, 2026

DEF 14A

Form DEF 14A - Other definitive proxy statements

Oct 31, 2025

PRE 14A

Form PRE 14A - Other preliminary proxy statements

Oct 20, 2025

Ownerships

TYPE

HEADLINE

FILED AT

SCHEDULE 13G/A

Dols Scott V. (Filed by)

Nov 3, 2026

SCHEDULE 13G/A

Kallman Craig (Filed by)

Oct 23, 2026

SCHEDULE 13G/A

NAGELBERG DAVID S (Filed by)

Aug 13, 2026

SCHEDULE 13G

Two Seas Capital LP (Filed by)

May 15, 2026

SCHEDULE 13G

FIRST MANHATTAN CO. LLC. (Filed by)

May 14, 2026

SCHEDULE 13G/A

Ayrton Capital LLC (Filed by)

May 11, 2026

Other

TYPE

HEADLINE

FILED AT

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 30, 2026

CORRESP

Form CORRESP - Correspondence

Apr 27, 2026

LETTER

Form UPLOAD - SEC-generated letter

Apr 24, 2026

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 18, 2025

EFFECT

Form EFFECT - Notice of Effectiveness

Apr 16, 2025

CORRESP

Form CORRESP - Correspondence

Apr 15, 2025

PAVmed Inc. PAVM · SEC Filings